Literature DB >> 21572766

Doing more with less?: past and present challenges for the FDA.

Jack McCain.   

Abstract

Year:  2011        PMID： 21572766      PMCID： PMC3086103     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  4 in total

1.  The Biosimilars Act: Promoting or Discouraging the Development of Generic Biologics?: A tug-of-war between generic and innovator biologics seems to be where drug developers are headed.

Authors:  Joanna T Brougher
Journal:  Biotechnol Healthc       Date:  2010

2.  Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.

Authors:  Peter Lurie; Cristina M Almeida; Nicholas Stine; Alexander R Stine; Sidney M Wolfe
Journal:  JAMA       Date:  2006-04-26       Impact factor: 56.272

3.  Paying for drug approvals--who's using whom?

Authors:  Jerry Avorn
Journal:  N Engl J Med       Date:  2007-04-13       Impact factor: 91.245

4.  A to-do list for the new FDA commissioner.

Authors:  Susan Okie
Journal:  N Engl J Med       Date:  2009-03-14       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.